Tag: MAGENTA

Paternal factors associated with short interpregnancy interval

Prenatal magnesium at 30-34 weeks does not reduce risk of death or cerebral palsy: MAGENTA trial

byLina Chenand1 others

September 15, 2023

1. Efficacy: There was no significant difference in death or cerebral palsy at 2 years between those who received magnesium ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Prenatal Systemic Glucocorticoid Exposure and an Increased Risk of Future Mental Disorders
Probiotic use may decrease risk factors for metabolic syndrome
Postdischarge contacts may not significantly affect unplanned healthcare utilization or patient satisfaction

No Result

View All Result